Evidence map›Paper›PMID 41264463›Full record

ArticleInterventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences2025

Middle meningeal artery embolization for chronic subdural hematoma using PHIL-LV: A case series.

Rudy Goh, Stephen Bacchi, Rebecca Scroop, Alistair Jukes, David J Taylor, Michael J Waters

Expression of concernAbstract read
In one paragraph

Article in Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It carries an expression of concern. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Rudy GohSouth Australian Medical Imaging Department, Royal Adelaide Hospital, Adelaide SA, Australia.ORCID 0000-0003-1645-2258
Stephen BacchiAdelaide Medical School, University of Adelaide, Adelaide SA, Australia.
Rebecca ScroopSouth Australian Medical Imaging Department, Royal Adelaide Hospital, Adelaide SA, Australia.
Alistair JukesSouth Australian Medical Imaging Department, Royal Adelaide Hospital, Adelaide SA, Australia.
David J TaylorSouth Australian Medical Imaging Department, Royal Adelaide Hospital, Adelaide SA, Australia.
Michael J WatersSouth Australian Medical Imaging Department, Royal Adelaide Hospital, Adelaide SA, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundChronic subdural hematoma (CSDH) is increasingly treated with middle meningeal artery embolization (MMAE). This study evaluated MMAE using a precipitating hydrophobic injectable liquid low viscosity (PHIL-LV) liquid embolic agent under general anaesthesia.MethodsConsecutive patients who underwent MMAE for CSDH with PHIL-LV at a single comprehensive neuroscience centre during a two-year period (2023-2025) were analysed. Patient clinical characteristics, imaging characteristics and procedural characteristics were recorded and described.ResultsTwenty-two patients (mean age 76 ± 13) were included in this study. Mean CSDH size was 18.4 ± 6.7 mm; 9/22 (40.9%) patients had a Charlson Comorbidity index >4. MMA embolization was successful in all 22/22 (100%) patients. Symptomatic improvement was observed in 14/17 (82.4%) of patients. During mean follow up (10.7 ± 9.2 (range 1-36)) weeks, mean reduction in CSDH thickness was 12.1 ± 9.9 mm; 13/16 (81.3%) patients had at least partial radiologic resolution of CSDH. No patients required retreatment.ConclusionPHIL-LV MMAE was safe and effective for treatment of CSDH in this case series.

Indexed as

Interventional radiologyliquid embolisationprecipitating hydrophobic injectable liquid low viscosityvascular neurology

Identifiers

PMID41264463
PMCPMC12634384

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.